TABLE 2.
Variable | mOS (m) | 95 % CI | p value |
---|---|---|---|
Any adjuvant therapy | 16.4 | 14–21 | 0.0007 |
No adjuvant therapy | 6.3 | 1.5–10.1 | |
Type of adjuvant therapy | |||
CT | 21.5 | 13.4–24.6 | 0.76 |
CRT | 16.8 | 13.9–23.1 | |
Lymph node statusa | |||
Negative | 24 | 19.8–34.2 | 0.0003 |
Positive | 13.8 | 10.9–15.2 | |
Resection margin status | |||
Negative (R0) | 16.6 | 13.4–20.1 | 0.36 |
Positive (R1)ab | 16.4 | 13.8–23.6 | |
Tumor size (cm) | |||
<3 | 16.4 | 12.1–21 | 0.0924 |
≥3 | 16.8 | 13.7–24 | |
Tumor differentiation | |||
Well-moderate | 15.2 | 8.7–25.6 | 0.54 |
Poor | 16.4 | 13.9–23 | |
Sex | |||
Male | 17.1 | 13.9–24.3 | 0.55 |
Female | 16.4 | 12.2–23.1 | |
Age (years) | |||
<70 | 20.4 | 13.7–29.9 | 0.0514 |
≥70 | 15.2 | 13.6–18.3 |
Bold values are statistically significant
In patients receiving adjuvant therapy
Microscopically positive